IP Library Granted Patent US 10,426,509
Granted Patent B2
US 10,426,509 · App. 14/089,760 · Granted Oct 1, 2019

Median lobe destruction apparatus and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,426,509
App. No.
14/089,760
Granted
Oct 1, 2019
Kind
B2
Abstract

A system and associated method for altering or destroying tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders. In one aspect, the system includes a device configured to deploy devices for altering the lobes of a prostate.

Claims (26)

1. A system for treating a median prostatic lobe of a patient, comprising:

a handle configured to remain outside the patient;

an actuator operable by a user after the system has been placed partially within a urethra;

an introducer coupled to the handle and configured to be placed within the urethra of the patient;

a needle advanceable from the introducer by operation of the actuator to move through a curved trajectory to align with the handle, the needle being extendable from a portion of the system placed within the urethra and the needle being sized and configured to form an initial penetration track within the median prostatic lobe, wherein the needle exits from a side of the introducer;

an elongate member including a cutting blade with a hooked distal end, the elongate member being advanceable within and beyond a distal end of the needle while the distal end of the needle is within the median prostatic lobe;

and an elongate cylindrical implant deliverable through the introducer to be implanted in a passageway through the median prostatic lobe;

wherein the system is configured to treat the median prostatic lobe by dissecting and removing a portion of the median prostatic lobe.

2. The system of claim 1 wherein the system is sized and configured to be advanced into an ejaculatory duct.

3. The system of claim 1 further comprising a vacuum element for applying vacuum to remove tissue from the median lobe.

4. The system of claim 1 , wherein the elongate member comprises articulating cutting arms configured to cut median lobe tissue.

5. The system of claim 1 , wherein the elongate member comprises an expandable cutter configured to cut median lobe tissue.

6. The system of claim 1 , wherein the elongate member comprises a blunt dissector configured to dissect median lobe tissue.

7. The system of claim 6 , wherein the blunt dissector further comprises a cutter blade.

8. The system of claim 1 further comprising a needle retraction lever that withdrawals the needle from the median prostatic lobe to be housed within the introducer.

9. The system of claim 1 wherein the needle is configured to advance from the introducer by means of hand, spring, electrical power or pneumatic power.

10. The system of claim 9 wherein the distal end of the needle is configured to receive positional feedback from the tissue and adjust the extension distance of the needle.

11. A device for intra-urethral treatment of a median prostatic lobe of a patient, comprising:

a handle configured to remain outside the patient and including an actuator operable by a user;

an introducer coupled to the handle and configured to be placed within the urethra of the patient;

a needle advanceable, by operation of the actuator, to exit from a side of the introducer to move through a curved trajectory to align with the handle and sized and configured to form an initial penetration track within the median prostatic lobe and configured to capture a dissected portion of the median prostatic lobe;

an elongate member carried by the needle and advanceable within and beyond a distal end of the needle while the distal end of the needle is within the median prostatic lobe, the elongate member comprising a cutting blade;

and an elongate cylindrical implant deliverable through the introducer to be implanted in a passageway through the median prostatic lobe.

12. The device of claim 11 wherein the elongate member is configured to dissect a portion of the median prostatic lobe.

13. The device of claim 11 wherein the needle is configured to be in fluid connection with a vacuum source.

14. The device of claim 11 wherein the introducer is configured to be in fluid connection with a vacuum source.

Assignments (10)
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066621/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066617/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066305/0073 →
MERGER Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066305/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2022
From: NEOTRACT, INC.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058917/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2021
From: NEOTRACT, INC.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058592/0907 →
SECURITY INTEREST Recorded Oct 3, 2019
From: NEOTRACT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 050619/0780 →
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NEOTRACT, INC.
Reel/Frame 044114/0608 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2017
From: MERRICK, DANIEL; CATANESE III, JOSEPH; TONG, LING-KANG; CHENG, FLORIA; GEARHART, MICHAEL; MCLEAN, MATTHEW; TACHIBANA, BRIAN Y; THOMPSON, BEN; NIEDERJOHN, JAMES W
To: NEOTRACT, INC.
Reel/Frame 041835/0446 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Mar 25, 2014
From: NEOTRACT, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 032525/0104 →